TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    3 Stocks to Avoid in a Market Correction

    Is the market going into a downturn? If so, here are three stocks you shouldn't hold.

    Read more »

    The Motley Fool
    Investing

    Can the TSX Rally Last?

    Canada’s stock exchange is the second-best-performing market after India, but can it keep going up?

    Read more »

    The Motley Fool
    Investing

    Which Health Care Stock Belongs in Your Portfolio?

    There isn't much to choose from in Canada, but with an aging population, this may be too good an opportunity…

    Read more »

    The Motley Fool
    Investing

    The Case For and Against Valeant Pharmaceuticals

    Here are three reasons for optimism and three reasons for caution.

    Read more »

    The Motley Fool
    Investing

    2 Stocks to Watch this Week

    BlackBerry and Valeant are in the spotlight this week.

    Read more »

    Investing

    2 Controversial Stocks With High Returns — Are They Worth the Risk?

    Valeant and CGI Group offer big returns, but there are reasons to be concerned.

    Read more »

    Investing

    Thinking of Buying Valeant? Consider These 2 Stocks Instead

    These two companies also have a remarkable track record, but aren't quite as polarizing.

    Read more »

    The Motley Fool
    Investing

    Is Valeant’s Big Offer for Allergan Big Enough?

    Or is Valeant set to offer even more?

    Read more »

    The Motley Fool
    Investing

    3 Top Stock Picks From Aurion Capital

    Aurion Capital's Greg Taylor revealed his favourite stock picks. Which of them should you add to your portfolio?

    Read more »

    The Motley Fool
    Investing

    Allergan Wants Nothing to Do With Valeant’s Stock. Should You?

    Breaking down Valeant-Allergan, potentially Canada's largest-ever acquisition. The most recent edition of Take Stock is here!

    Read more »

    The Motley Fool
    Investing

    Valeant’s Pursuit of Allergan: Go Big or Go Home

    Only a very good offer will entice Allergan shareholders.

    Read more »

    The Motley Fool
    Investing

    5 Can’t-Miss Investing Headlines This Week

    Canada's job market disappoints. Valeant up the ante for Allergan. And is Sears Canada doomed?

    Read more »